[New drugs in early clinical trials and drug resistance--US-Japan joint seminar].
作者信息
Ogawa M
机构信息
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Japan.
出版信息
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):697-700.
PMID:2321989
Abstract
摘要
相似文献
1
[New drugs in early clinical trials and drug resistance--US-Japan joint seminar].[早期临床试验中的新药与耐药性——美日联合研讨会]
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):697-700.
2
[Present strategy for new drug development in the USA].[美国新药研发的当前策略]
Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:315-24.
3
[Research project of cancer chemotherapy].[癌症化疗研究项目]
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):595-600.
4
Cancer drug approval in the United States, Europe, and Japan.美国、欧洲和日本的癌症药物批准情况。
Adv Cancer Res. 2007;96:371-91. doi: 10.1016/S0065-230X(06)96012-6.
5
[Impact of rapid advancement of international standardization on technical requirements for new drug registration].[国际标准化快速推进对新药注册技术要求的影响]
Gan To Kagaku Ryoho. 1996 Apr;23(5):509-16.
6
European collaboration in trials of new agents for children with cancer.欧洲在儿童癌症新药物试验方面的合作。
Eur J Cancer. 2004 Aug;40(12):1886-92. doi: 10.1016/j.ejca.2004.05.011.
7
[The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].[日本抗癌药物临床评价方法指南的修订]
Gan To Kagaku Ryoho. 2006 Jul;33(7):1015-9.
8
[Contribution of Japan to develop new anticancer agents].
Gan To Kagaku Ryoho. 1996 Jan;23(2):242-6.
9
[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].新修订的《药物临床试验质量管理规范》下抗癌药物的研发——从药物研发公司开发者的角度来看
Gan To Kagaku Ryoho. 1998 Apr;25(5):663-70.
10
[Participation to international registration trials--from the investigator's standpoint].[从研究者角度看参与国际注册试验]
Gan To Kagaku Ryoho. 2007 Feb;34(2):297-300.
Zotero 插件